You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 15 No. 1, July 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (178)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex on Guam

Further Pathologic Studies

ASAO HIRANO, MD; NATHAN MALAMUD, MD; TERESITA S. ELIZAN, MD; LEONARD T. KURLAND, MD

Arch Neurol. 1966;15(1):35-51.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE EXTRAORDINARY prevalence of fatal neurological diseases on Guam has evoked the interest of a number of investigators for the last 15 years. The best known diseases affecting the indigenous Chamorro people are a type of amyotrophic lateral sclerosis (ALS), apparently unique to Guam,1 where, in addition to the classical histological changes of ALS, Alzheimer's neurofibrillary changes are present in specific parts of the central nervous system (CNS); and parkinsonism dementia complex (PD) in which the same neurofibrillary changes are consistently observed.2

At this point one may obviously ask whether these diseases are two distinct entities or are in some way related. This relationship has recently been discussed from the clinical3 and epidemiological4 stand-points. In this paper we would like to provide neuropathological evidence for such a relationship. For this purpose we have examined tissues associated with both diseases regardless of the principal clinical . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK; SAN FRANCISCO; BETHESDA, MD; ROCHESTER, MINN

From Henry and Lucy Moses Research Laboratories of the Laboratory Division, Montefiore Hospital and Medical Center, Bronx, NY. Visiting Scientist, Epidemiology Branch, National Institute of Neurological Diseases and Blindness (NINDB), National Institutes of Health (NIH), and now neuropathologist, Laboratory Division, Montefiore Hospital and Medical Center, New York (Dr. Hirano); Professor of Psychiatry and Neuropathology, University of California, San Francisco (Dr. Malamud); formerly Visiting Scientist (Neurologist), NINDB Research Center, Guam, and now neurologist, NINDB, NIH, Bethesda, Md (Dr. Elizan); and formerly Chief, Epidemiology Branch, NINDB, NIH, and now Chief, Section of Medical Statistics, Epidemiology and Population Genetics, Mayo Clinic, Rochester, Minn (Dr. Kurland).


Footnotes

Submitted for publication March 9, 1966; accepted March 22.

Reprint requests to the Laboratory Division, Montefiore Hospital and Medical Center, Bronx, NY 10467 (Dr. Hirano).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.